Klumper is replacing Eric van der Putten who leaves his role as CEO to become Chief Business Development Officer, responsible for driving new business opportunities and growing SMS Oncology’s client base.
“Our clients will benefit discussing their new cancer studies with Eric who brings to the table 30+ years of experience in running phase I and II cancer trials in close collaboration with the top tier of oncologists,” said new CEO Edwin Klumper. “His experience and operational insights will be of great value to our clients in achieving their objectives.”
The latest hires in pharmaceutical outsourcing in this week's column.
The latest CRO, CMO and commercial services appointments worldwide.
New CEOs, Commercial Directors and more in this week's column.
With the World Cup as a background theme, DIA celebrated its 50th anniversary as a conference with...